Published:
Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties
MINNEAPOLIS, July 3 /PRNewswire/ -- The Eniva Research Group has released
results from aboratory testing by the world-famous Linus Pauling Micronutrient
Research Institute at Oregon State University which demonstrated the Eniva
Health Supplement VIBE(R) possessed DNA protective anti-mutagenic activity for
human cells. This third party testing was performed as part of an ongoing
investigative effort to further identify mechanisms by which the Eniva VIBE
nutraceutical impacts human health.
Chief Scientific Officer for Eniva Corporation, Dr. Benjamin Baechler,
stated, "While these results are tremendously exciting and give us insight
into one of the mechanisms of action of the VIBE nutraceutical, we must be
careful not to generalize these results beyond the study findings. What we
can say for certain is these results further demonstrate the ability of the
VIBE nutraceutical to help support healthy and normal functioning of human
cells, even under very stressful physiologic situations."
The research design consisted of culturing human cells with and without
the VIBE nutraceutical and then exposing these human cells to a well known DNA
mutagen-ultraviolet radiation. After a period of time, the human skin cells
were then obtained and examined for specific damage to their DNA. Results
were compared between the human cells supported by VIBE in their growth medium
and those without it. The results demonstrated an extremely statistically
significant decrease in DNA damage in those human cells which were supported
with the VIBE nutraceutical (p-value < 0.001).
The exact laboratory technique used was the COMET assay, otherwise known
as Single-Cell Gel Electrophoresis (SCGE), which is a very sensitive and
well-known peer accepted laboratory method for assessing damage to cellular
DNA. The COMET assay is widely used to assess DNA damage in cancer research,
environmental toxicology and radiation biology. After mutagen exposure, cells
are embedded in agarose gel on a microscope slide, lysed, electrophoresed, and
then stained with fluorescent DNA binding dye. Damaged DNA migrates during
the process, forming a shape often described as a "comet." The specific
pattern is then automatically quantified through laser assisted computer
analysis. Through specific algorithms, DNA damage can then be quantified and
trends evaluated.
These results are part of an intensive initiative by the Eniva Corporation
to further explore the mechanism of action behind their nutraceutical
products. Chairman of Eniva Corporation, Andrew Baechler, commented, "This
result further identifies and separates Eniva as a leader in providing
science-based dietary solutions. We are very enthusiastic about the findings
and are very grateful to our collaborators at the Linus Pauling Micronutrient
Research Institute."
Eniva Corporation is a manufacturer and global marketer of high quality,
science-based dietary supplements known as nutraceuticals. It carries a
product line of over 75 wellness products, ranging from cardiovascular to
general health and wellness. The corporation recently celebrated its tenth
year anniversary at its world headquarters inAnoka, Minnesota. More
information on this topic and the actual testing data can be found at
http://www.enivanutraceutics.com.
SOURCE Eniva
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily NewsTags: Healthcare, Pharmaceuticals, Biotechnology, Health, , minnesota
_ _Is your favorite bookmark site missing?
Ask for it.
Search News
Daily News
